SPDR S&P Kensho Final Frontiers ETF (ARCA: ROKT)

Dernières nouvelles pour SPDR S&P Kensho Final Frontiers ETF (ARCA:ROKT)

Industrials

Technology

Energy

Consumer Cyclical

Communication Services

Financial Services

Healthcare

Real Estate

Other

Consumer Defensive

Utilities

Basic Materials

Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index is designed to capture companies whose products and services are driving innovation behind the exploration of deep space and deep sea. The fund may invest in equity securities that are not included in the index, cash and cash equivalents or money market instruments. It is non-diversified.

Oceaneering International Inc

Lockheed Martin Corp

Moog Inc

Northrop Grumman Corp.

Rocket Lab Usa Inc

Raytheon Technologies Corp

Heico Corp.

Teledyne Technologies Inc

Boeing Co

Iridium Communications Inc

SPDR S&P Kensho Final Frontiers ETF

<p><strong>Goldman Sachs</strong> analyst Jordan Alliger reiterated the Buy rating on <strong>J.B. Hunt Transport Services, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>).</p>
<p>The analyst&#8217;s take on <strong>J.B. Hunt</strong> suggests a positive outlook. The company showed a 5% growth in intermodal in the third quarter of 2024, driven by a 7% increase in transcontinental and <a target="_blank" href="https://www.benzinga.com/quote/jbht/analyst-ratings" rel="noreferrer noopener">double-digit growth in Southern California.</a></p>
<p>However, according to Alliger, the company&#8217;s intermodal growth lags behind the &#8220;Big Three&#8221; ports, which saw an average increase of 27.5%.</p>
<p>The Big Three West Coast Ports, represented by L.A., Long Beach, and Oakland, reported a 20% year-over-year increase in November 2024 traffic, surpassing the pre-pandemic five-year average of 2%.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/24/12/42701686/bitcoin-could-slide-to-60000-technical-analyst-warns" rel="noreferrer noopener">Bitcoin Could Slide To $60,000, Technical Analyst Warns</a></strong></p>
<p>However, sequentially, the combined data showed a 6% month-over-month decline, which is below the five-year average.</p>
<p>Despite this, the analyst predicts that the pace of growth could pick up again for J.B. Hunt<strong> </strong>toward the end of 2024 and into 2025, ahead of any potential tariffs.</p>
<p>The shift towards domestic intermodal is showing positive signs, and there is potential for more imports to move out of West Coast warehouses.</p>
<p>The West Coast ports, regaining share in 2023 and 2024, may further boost J.B. Hunt&#8217;s performance if more ocean freight is diverted to the West Coast amid ongoing contract uncertainties on the East Coast. Despite this, the company&#8217;s growth is still behind the broader industry&#8217;s pace, but the outlook remains favorable with potential upside, Alliger adds.</p>
<p><strong>Price Action: </strong>JBHT shares are trading lower by 0.76% to $170.70&nbsp;at the last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42699697/bitcoin-ethereum-etfs-break-4-day-outflow-streak-net-592-inflows-on-thursday" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum ETFs Break 4-Day Outflow Streak, Net $592 Inflows On Thursday</a></strong></li>
</ul>
<p><em>Photo via Wikimedia Commons</em></p>


Analyst Color

Equities

News

Markets

Analyst Ratings

Movers

Trading Ideas

General

JBHT

J.B. Hunt's Intermodal Growth Shows Promise Despite Lagging 'Big Three' Ports: Analyst

<p><strong>Johnson &amp; Johnson</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), the iconic healthcare giant known for its stable dividends and defensive appeal, has entered a bearish technical pattern: <a href="https://www.benzinga.com/topic/death-cross">the <strong>Death Cross</strong></a>. </p>
<p>This occurs when the stock's 50-day moving average falls below its 200-day moving average, signaling potential downside.</p>
<p><figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="810" height="546" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross.jpg" alt="" class="wp-image-709568" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross.jpg 810w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross-300x202.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross-768x518.jpg 768w" sizes="(max-width: 810px) 100vw, 810px" /></a></figure></p>
<p><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><em>Chart created using Benzinga Pro</em></a></p>
<h2 class="wp-block-heading">JNJ Stock Chart: Bearish Signals Abound</h2>
<p>JNJ stock, at $145.58, is below critical moving averages across the board. Its 20-day ($144.97), 50-day ($154.24) and 200-day ($154.66) moving averages suggest the trend is firmly bearish. With a MACD of a negative 2.72 and a Relative Strength Index of 36.84, the technical setup doesn't inspire confidence.</p>
<p>The one silver lining? JNJ stock's eight-day simple moving average of $144.97 is slightly below its current price, flashing a rare bullish signal amid the gloom.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/general/biotech/24/12/42535810/fda-rejects-johnson-johnsons-injectable-version-of-approved-drug-for-lung-cancer">FDA Rejects Johnson &amp; Johnson&#8217;s Injectable Version Of Approved Drug For Lung Cancer</a></strong></p>
<h2 class="wp-block-heading">Johnson &amp; Johnson&#8217;s Strategic Moves In Dermatology</h2>
<p>While the charts tell one story, Johnson &amp; Johnson's business narrative points to another. The company recently inked a licensing deal with Kaken Pharmaceutical for KP-723, a promising candidate targeting atopic dermatitis (AD), also known as eczema. With plans to launch a phase I study in 2025, Johnson &amp; Johnson is positioning itself to address significant unmet needs in autoimmune and allergic diseases.</p>
<p>This move aligns with the company's strategic focus on differentiated mechanisms of action in dermatology. Johnson &amp; Johnson's acquisitions in 2024 also bolstered its dermatology pipeline, emphasizing innovative treatments for AD and other immune-mediated conditions.</p>
<h2 class="wp-block-heading">Dividend Reliability Meets Bearish Momentum</h2>
<p>Johnson &amp; Johnson's long-standing reputation as a dividend aristocrat—boasting 60+ years of consistent payouts—continues to provide a safety net for investors. </p>
<p>With ample liquidity, low leverage, and robust free cash flow, the company's dividend sustainability remains solid even in the face of technical bearishness.</p>
<h2 class="wp-block-heading">The Verdict</h2>
<p>The Death Cross may cast a shadow over Johnson &amp; Johnson stock's short-term outlook, but its commitment to growth, innovation, and reliable dividends underscores its long-term appeal. </p>
<p>Investors should weigh JNJ stock&#8217;s bearish technical indicators against the company's strategic moves in dermatology and its history of weathering market storms.</p>
<p>As Johnson &amp; Johnson looks to tackle eczema and diversify its portfolio, the stock may be down but far from out. For now, the Death Cross is a storm cloud on the horizon—but every storm eventually passes.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://benzinga.com/analyst-ratings/analyst-color/24/12/42678014/top-7-blue-chip-stocks-with-the-best-return-potential-going-into-2025">Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025</a></strong></li>
</ul>
<p><em>Photo by Tada Images via Shutterstock</em>.</p>


Biotech

Health Care

Technicals

Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise

WIIM

Rumble shares are trading lower, possibly pulling back after the stock's recent surge.

<p>Looking into the current session, <strong>Bank of New York Mellon Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>)</strong> shares are trading at $77.72, after a <strong>0.80%</strong> decrease. Over the past month, the stock decreased by <strong>5.62%</strong>, but over the past year, it actually spiked by <strong>47.51%</strong>. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735324215_0.png" alt="Past Year Chart" /></p>

<h3>A Look at Bank of New York Mellon P/E Relative to Its Competitors</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Bank of New York Mellon has a lower P/E than the aggregate P/E of <strong>43.67</strong> of the Capital Markets industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735324215_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


Intraday Update

Price Over Earnings Overview: Bank of New York Mellon

<p>Jensen Huang, the CEO and cofounder of Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), is making headlines for more than just his company's dominance in AI chips. Huang is allegedly leveraging <a href="https://www.benzinga.com/money/how-to-reduce-taxable-income-for-high-earners">legal tax strategies</a> to protect an estimated $8 billion from federal estate and gift taxes, according to a recent investigation by The New York Times. This staggering number has spurred a wider discussion about how the ultrawealthy use legal loopholes to safeguard their money.</p>
<h2 class="wp-block-heading">The NYT's Findings on Huang's Wealth Strategies</h2>
<p>Huang&#8217;s net worth was $127 billion when the report was released in early December. According to the NYT, he has used a number of financial strategies to <a href="https://www.benzinga.com/money/ownwell">reduce estate taxes</a>. These include instruments such as donor-advised funds (DAFs), grantor-retained annuity trusts (GRATs) and irrevocable trusts. By doing so, Huang could pass on much of his fortune to his descendants with minimal tax liability.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</strong></a></strong></li>
<li><strong>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"><strong> </strong><strong>for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</strong></a></strong></li>
</ul>
<p>One of the most notable examples cited by the NYT involves an irrevocable trust Huang and his wife set up in 2012. They transferred Nvidia shares worth $7 million into the trust, which has since grown in value to over $3 billion. Normally, the tax on that kind of wealth would be about 40%, but the trust helps them pay much less – perhaps just a few hundred thousand dollars.</p>
<p>As Lewis &amp; Clark Law School professor Jack Bogdanski told the NYT, "You have an army of well-trained, brilliant people who sit there all day long, charging $1,000 an hour, thinking up ways to beat this tax. Don't expect anyone in Congress to stop this."</p>
<p><strong>See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks"><strong>this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</strong></a></strong></p>
<h2 class="wp-block-heading">What's the Bigger Picture?</h2>
<p>The NYT&#8217;s investigation provides a broader view of the continuous erosion of estate taxes over time. Huang&#8217;s tactics are becoming increasingly popular, even though these taxes are meant to impact only the wealthiest Americans. Thanks to these methods, experts estimate that about $200 billion gets passed down each year without being taxed.</p>
<p>To make matters worse, funding constraints have reduced the Internal Revenue Service&#8217;s (IRS) ability to enforce the law. During the early 1990s, audits of more than 20% of estate tax returns were conducted. The NYT reports that number has now fallen to roughly 3%.</p>
<p><strong>Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"><strong> </strong><strong>you can become an investor for $0.80 per share today.</strong></a></strong></p>
<h2 class="wp-block-heading">Charitable Contributions and Scrutiny</h2>
<p>While Huang's philanthropy is well-documented, critics also scrutinized his use of DAFs, which lack transparency and accountability. Through the Jen Hsun &amp; Lori Huang Foundation, the couple has <a href="https://www.benzinga.com/startups/24/10/41124309/nvidias-jensen-huangs-wealth-exploded-in-five-years-to-108-billion-heres-why-his-philanthropy-is-bei">donated Nvidia shares</a> worth hundreds of millions of dollars to these funds. Although these contributions reduce Huang's taxable estate, the funds are not required to distribute money to charities immediately, leaving room for criticism about their actual societal impact.</p>
<h2 class="wp-block-heading">The Debate Continues</h2>
<p>Huang's financial strategies highlight the growing divide between the ultrawealthy and the <a href="https://www.benzinga.com/general/24/04/38295912/biden-promised-irs-funding-wouldnt-increase-audits-for-regular-americans-as-irs-audits-poorest-ameri">broader taxpaying public</a>. While these tactics are legal, they underscore how accessible loopholes can result in massive tax savings for billionaires. As the debate over wealth inequality and tax fairness continues, Huang's story may become a case study in how the richest Americans protect their fortunes.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>with $1,000 you can invest at just $0.26/share!</strong></a></strong></li>
<li><strong>If there was a new fund backed by Jeff Bezos offering a</strong><strong> <a href="https://www.benzinga.com/money/arrived-private-credit-fund"><strong>7-9% target yield with monthly dividends would you invest in it</strong></a>?</strong></li>
</ul>


NVDA

NYT Report Says Jensen Huang, The CEO Of Nvidia And The 10th-Richest Person In The U.S., Trying To Allegedly Avoid $8 Billion In Taxes

GDS shares are trading higher on continued strength following a Tuesday report suggesting the company is considering an IPO of its data center assets in China.

<p>Wall Street turned volatile Friday as four days of gains give way to fresh selling pressure driven by investor uncertainty over the incoming Trump administration&#8217;s economic policies and the <a href="https://www.benzinga.com/topic/federal-reserve">Federal Reserve&#8217;s path forward.</a></p>
<p>Major indices experienced wide losses by midday trading in New York, nearly erasing prior gains seen earlier this week, clouding the outlook for a Santa Rally.</p>
<p>The tech-heavy Nasdaq 100 tumbled 2%, on track for its second-worst session this month. Both the S&amp;P 500 and the Dow saw notable losses, while small caps underperformed large-cap counterparts.</p>
<p>On the data front, the U.S. goods trade deficit widened to $102.86 billion in November 2024, surpassing expectations of $100.7 billion, as imports jumped 4.5%, according to an advance official estimate.</p>
<p>Treasury yields were little moved but remained elevated, with the long-dated 30-year yield hovering at the highest levels since May. </p>
<p>In commodities markets, oil emerged by rising 1%, with West Texas Intermediate light crude topping $70 per barrel amid recent declines in in commercial crude inventories.</p>
<p>In cryptocurrency markets <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dropped 1.7% to $94,000, heading for its second consecutive weekly loss— the first since September.</p>
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<tbody>
<tr>
<td><strong>Major Indices</strong></td>
<td><strong>Price</strong></td>
<td><strong>Chg</strong></td>
<td><strong>1-day %</strong></td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,739.03</td>
<td>-586.77</td>
<td>-1.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,934.68</td>
<td>-102.91</td>
<td>-1.7%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,326.63</td>
<td>-441.68</td>
<td>-2.0%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,226.71</td>
<td>-53.48</td>
<td>-2.3%</td>
</tr>
</tbody>
</table>
<p><figcaption class="wp-element-caption"><em>Updated at 12:15 p.m. ET</em></figcaption></p></figure></p>
<p><strong>According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:</strong></p>
<ul>
<li>The&nbsp;<strong>SPDR S&amp;P 500 ETF Trust</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 1.6% to $591.61.</li>
<li>The&nbsp;<strong>SPDR Dow Jones Industrial Average&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 1.2% to $427.96.</li>
<li>The tech-heavy&nbsp;<strong>Invesco QQQ Trust Series</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) tumbled 2.1% to $518.58.</li>
<li>The&nbsp;<strong>iShares Russell 2000 ETF</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 2.3% to $220.55.</li>
<li>The&nbsp;<strong>Energy Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, flat for the day; the&nbsp;<strong>Technology Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 2.4%.</li>
</ul>
<h3 class="wp-block-heading">Friday Stock Movers</h3>
<ul>
<li><strong>Tesla Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) sank 4.8% as investors reassessed its valuation after a 73% year-to-date surge.</li>
<li>Crypto-related stocks pulled back strongly: <strong>KULR Technology Group Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) tumbled 7.4%, <strong>MicroStrategy Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) slipped 3.6% and <strong>Coinbase Global Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) fell 3.5%. </li>
<li><strong>Lamb Weston Holdings Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) gained 3.6% after shareholder <strong>Jana Partners</strong> added<strong> Jeff Delapp</strong> to its board nominee slate, signaling a potential board overhaul, according to a Friday regulatory filing.</li>
</ul>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/travel/24/12/42705878/airline-stocks-outperform-tech-in-2024-holiday-travel-expected-to-see-records-this-year">Airline Stocks Outperform Tech In 2024: Holiday Travel &#8216;Expected To See Records This Year&#8217;</a></strong></li>
</ul>
<p><em>Photo via Shutterstock. </em></p>


Large Cap

Bonds

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

COIN

SPDR Dow Jones Industrial Average ETF Trust

KULR

MSTR

TSLA

Stocks Tumble As Traders Rethink Santa Rally, Crude Tops $70, Bitcoin Slips To $94,000: What's Driving Markets Friday?

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Qualcomm</strong>.</p>
<p>Looking at options history for Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) we detected 10 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $103,238 and 7, calls, for a total amount of $449,504.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $200.0 for Qualcomm over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Qualcomm options trades today is 1371.1 with a total volume of 892.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Qualcomm's big money trades within a strike price range of $105.0 to $200.0 over the last 30 days.</p>
<h3>Qualcomm Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735323340_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.0</td>
<td>$5.5</td>
<td>$5.5</td>
<td>$155.00</td>
<td>$194.1K</td>
<td>5.5K</td>
<td align="right">371</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$55.0</td>
<td>$49.95</td>
<td>$52.79</td>
<td>$125.00</td>
<td>$52.7K</td>
<td>49</td>
<td align="right">10</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$13.35</td>
<td>$13.3</td>
<td>$13.35</td>
<td>$165.00</td>
<td>$52.0K</td>
<td>2.5K</td>
<td align="right">52</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$52.55</td>
<td>$51.5</td>
<td>$51.5</td>
<td>$105.00</td>
<td>$51.5K</td>
<td>1.2K</td>
<td align="right">10</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$1.18</td>
<td>$1.1</td>
<td>$1.1</td>
<td>$175.00</td>
<td>$44.0K</td>
<td>76</td>
<td align="right">402</td>
</tr>
</tbody>
</table>
</p>
<h3>About Qualcomm</h3>
<p>Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.</p>
<p>Following our analysis of the options activities associated with Qualcomm, we pivot to a closer look at the company's own performance.</p>
<h3>Qualcomm's Current Market Status</h3>
<ul>
<li>With a volume of 1,611,809, the price of QCOM is down -1.23% at $156.58. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 33 days.</li>
</ul>
<h3>Professional Analyst Ratings for Qualcomm</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $180.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Melius Research lowers its rating to Hold with a new price target of $180.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Qualcomm with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

QCOM

Behind the Scenes of Qualcomm's Latest Options Trends

<p>Deep-pocketed investors have adopted a bullish approach towards Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMGN usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for Amgen. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 42% bearish. Among these notable options, 9 are puts, totaling $525,048, and 5 are calls, amounting to $288,709.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $245.0 and $320.0 for Amgen, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for Amgen options trades today is 139.83 with a total volume of 1,014.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Amgen's big money trades within a strike price range of $245.0 to $320.0 over the last 30 days.</p>
<h3>Amgen Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735323335_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$34.8</td>
<td>$34.25</td>
<td>$34.8</td>
<td>$280.00</td>
<td>$191.3K</td>
<td align="right">110</td>
<td align="right">55</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$17.35</td>
<td>$17.3</td>
<td>$17.35</td>
<td>$270.00</td>
<td>$104.0K</td>
<td align="right">18</td>
<td align="right">64</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$24.7</td>
<td>$22.3</td>
<td>$22.8</td>
<td>$310.00</td>
<td>$57.0K</td>
<td align="right">33</td>
<td align="right">28</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$30.85</td>
<td>$30.65</td>
<td>$30.85</td>
<td>$270.00</td>
<td>$52.4K</td>
<td align="right">289</td>
<td align="right">18</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$35.1</td>
<td>$34.5</td>
<td>$34.67</td>
<td>$295.00</td>
<td>$52.0K</td>
<td align="right">97</td>
<td align="right">24</td>
</tr>
</tbody>
</table>
</p>
<h3>About Amgen</h3>
<p>Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.</p>
<h3>Amgen's Current Market Status</h3>
<ul>
<li>Trading volume stands at 582,871, with AMGN's price down by -0.55%, positioned at $261.73.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 39 days.</li>
</ul>
<h3>What The Experts Say On Amgen</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $256.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from B of A Securities downgraded its action to Underperform with a price target of $256. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


AMGN

Looking At Amgen's Recent Unusual Options Activity

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Verizon Communications</strong>.</p>
<p>Looking at options history for Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) we detected 9 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 33% with bearish.</p>
<p>From the overall spotted trades, 6 are puts, for a total amount of $327,928 and 3, calls, for a total amount of $247,780.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $34.0 to $47.0 for Verizon Communications over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Verizon Communications's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Verizon Communications's whale activity within a strike price range from $34.0 to $47.0 in the last 30 days. </p>
<h3>Verizon Communications Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735323330_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>VZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$6.35</td>
<td>$6.3</td>
<td>$6.35</td>
<td>$34.00</td>
<td>$156.8K</td>
<td>467</td>
<td align="right">248</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$8.3</td>
<td>$8.2</td>
<td>$8.3</td>
<td>$47.00</td>
<td>$100.4K</td>
<td>1.1K</td>
<td align="right">122</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.15</td>
<td>$3.1</td>
<td>$3.15</td>
<td>$42.00</td>
<td>$81.2K</td>
<td>7.5K</td>
<td align="right">258</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.75</td>
<td>$6.35</td>
<td>$6.4</td>
<td>$45.00</td>
<td>$64.0K</td>
<td>1.9K</td>
<td align="right">100</td>
</tr>
<tr>
<td>VZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.55</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$38.00</td>
<td>$52.5K</td>
<td>782</td>
<td align="right">158</td>
</tr>
</tbody>
</table>
</p>
<h3>About Verizon Communications</h3>
<p>Wireless services account for about 70% of Verizon Communications' total service revenue and nearly all of its operating income. The firm serves about 93 million postpaid and 20 million prepaid phone customers via its nationwide network, making it the largest US wireless carrier. Fixed-line telecom operations include local networks in the Northeast, which reach about 30 million homes and businesses and serve about 8 million broadband customers. Verizon also provides telecom services nationwide to enterprise customers, often using a mixture of its own and other carriers' networks. Verizon agreed to acquire Frontier Communications in September 2024.</p>
<h3>Where Is Verizon Communications Standing Right Now?</h3>
<ul>
<li>With a volume of 6,649,497, the price of VZ is down -0.25% at $39.86. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 28 days.</li>
</ul>
<h3>What Analysts Are Saying About Verizon Communications</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $45.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from UBS persists with their Neutral rating on Verizon Communications, maintaining a target price of $45. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Verizon Communications options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Verizon Communications Unusual Options Activity

Macro Economic Events

Oil is trading higher. Chinese stimulus hopes may be lifting demand outlook. Additionally, EIA reported a larger-than-expected draw in US crude inventories.

Commodities

U.S. Baker Hughes Oil Rig Count Unchanged At 483

ATNF

180 Life Sciences Corp. shares are trading lower after the company announced the pricing of a $2.9 million registered direct offering.

USA Gasoline Inventories 1.630M Vs -1.000M Est.; 2.348M Prior

USA EIA Weekly Distillates Stocks -1.694M Vs -0.700M Est.; -3.180M Prior

USA Crude Oil Inventories -4.237M Vs -0.700M Est.; -0.934M Prior

AMZN

iShares Dow Jones US Oil & Gas Exploration & Production Index Fund

SBRA

CNBC Final Trades: iShares US Oil & Gas Exploration & Production ETF, Amazon, Sabra Health Care REIT

<p>In the current session, <strong>Universal Display Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>)</strong> is trading at $150.69, after a <strong>0.10%</strong> drop. Over the past month, the stock fell by <strong>10.11%</strong>, and in the past year, by <strong>20.74%</strong>. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735322411_0.png" alt="Past Year Chart" /></p>

<h3>A Look at Universal Display P/E Relative to Its Competitors</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Compared to the aggregate P/E ratio of the <strong>59.02</strong> in the Semiconductors &amp; Semiconductor Equipment industry, Universal Display Inc. has a lower P/E ratio of <strong>30.29</strong>. Shareholders might be inclined to think that  the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735322411_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


OLED

P/E Ratio Insights for Universal Display

<p>Seadrill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDRL#NYSE">SDRL</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Seadrill, presenting an average target of $72.5, a high estimate of $80.00, and a low estimate of $50.00. Observing a 0.69% increase, the current average has risen from the previous average price target of $72.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735322410_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Seadrill. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hamed Khorsand</td>
<td>BWS Financial</td>
<td>Maintains</td>
<td>Buy</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Nikhil Gupta</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Hamed Khorsand</td>
<td>BWS Financial</td>
<td>Maintains</td>
<td>Buy</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Hamed Khorsand</td>
<td>BWS Financial</td>
<td>Maintains</td>
<td>Buy</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Seadrill. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Seadrill compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Seadrill's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Seadrill's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SDRL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Seadrill analyst ratings.</strong></a></p>
<h2>Discovering Seadrill: A Closer Look</h2>
<p>Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from the United States.</p>
<h3>Seadrill's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Challenges:</strong> Seadrill's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately <strong>-14.49%</strong>. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.</p>
<p><strong>Net Margin:</strong> Seadrill's net margin is impressive, surpassing industry averages. With a net margin of <strong>9.04%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Seadrill's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>1.07%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Seadrill's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.76%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Seadrill's debt-to-equity ratio is below the industry average. With a ratio of <b>0.21</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SDRL

Where Seadrill Stands With Analysts

TANH

Tantech Holdings shares are trading higher after the company announced the company's subsidiary, Gohomeway Group, signed an annual purchase agreement with Heidi Enterprise Group for the period of January 2025 to December 2025.

Portfolio Implications Of Powell's 'Whatever It Takes' Moment

Resilient U.S. Retail Sales Suggests Fed Decision Will Be A Coin Toss

SPDR S&P Kensho Final Frontiers ETF declares quarterly distribution of $0.0617

Can Remarkable U.S. Industrial Revenues Continue?

Amid The Noise: Four U.S. Value Equity Themes To Monitor

As Markets Sit Near Record Highs, Does This Rally Still Have Room To Run?

Brad Simpson On The Election, Economy, And Why Markets Are Ready To Get 'Back To Business'

Back To Business

PPA: Defense Stocks ETF Positioned To Soar

SPDR S&P Kensho Final Frontiers ETF declares quarterly distribution of $0.1374

AAAU

ACTV

AFMC

AFSM

AIRR

ARKF

ARKK

ARKQ

ARKW

ARTY

AVUV

AXON

BAPR

BBRE

BBSC

BDCZ

BGLD

BITQ

BIZD

BKSE

BLCN

BLOK

BOIL

CALF

CBSE

CIBR

CLNR

CLOU

CNRG

CRAK

DEEP

DFAS

DFNL

DGRS

DPST

DTEC

DUSL

DWAS

EBIZ

ESML

ESPO

FDIS

FDRV

FENY

FIBR

FIDU

FILL

FINX

FITE

FLQS

FNCL

FNDA

FNGS

FPRO

FREL

FSTA

FTEC

FTXL

FTXN

FTXO

FTXR

GAMR

GBIL

GBUY

GLDI

GLDM

GLRY

GLTR

GOVT

GOVZ

GRNTF

GSSC

HACK

HDRO

HERO

HOMZ

HSMV

IAUM

IBUY

IDGT

IDRV

IEDI

IETC

IGLD

IGPT

IHAK

INDS

ISCB

ISCG

ISCV

ISHP

ISMD

ITEQ

IVOO

Comments

SPDR S&P Kensho Final Frontiers ETF

Actualités

Dernières nouvelles pour SPDR S&P Kensho Final Frontiers ETF (ARCA:ROKT)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL